InsidersTradesSigma
Follow the 安图生物 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 安图生物 has recorded 2 insider filings. Market capitalisation: €18.7bn. The latest transaction was reported on 4 July 2024 (Purchase). Among the most active insiders: 苗拥军. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
安图生物 es una empresa enfocada en el sector de la salud y farmacéutico, que provee soluciones de diagnóstico y productos biofarmacéuticos. Cotiza en el mercado XSHG.